Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit I 1 1.0 Introduction M/s. Sri Krishna Pharmaceuticals Limited. (hereinafter referred to as “SKPL or Industry”) is located at C-4, IDA, Uppal, RangaReddy District in Telangana. The unit was established in 1975 and obtained Environmental Clearance from MOEF vide Order Post Ex facto No j-11011/151/2005- IA.II(I) Dt Aug 11,2005 to manufacture Paracetamol with a capacity of 200 TPM. Subsequently obtained CFE of the Board vide letter No: 62/PCB/CFE/RO-I-RRD/HO/2010-2289 for change of product mix by adding two low volume products with a total capacity of 193.42 TPM. As product pricing came down drastically over the period, it is necessary to achieve economic scale of production. In order to achieve this now Sri Krishna Pharmaceuticals Limited proposed to expand the production Capacity from 200 MTPM to 2021.68 MTPM A copy of the environmental clearance obtained from MOEF, Government of India in 2005 and certified copy of compliance report obtained MOEF, Government of India, Bangalore Regional office is enclosed at Annexure I
39
Embed
1.0 Introduction - environmentclearance.nic.inenvironmentclearance.nic.in/writereaddata/EIA/150420157B9XC3JIPrefeasibilityreport.pdfNearest railway station and distance Secunderabad-
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit I
1
1.0 Introduction
M/s. Sri Krishna Pharmaceuticals Limited. (hereinafter referred to as
“SKPL or Industry”) is located at C-4, IDA, Uppal, RangaReddy District in
Telangana. The unit was established in 1975 and obtained Environmental
Clearance from MOEF vide Order Post Ex facto No j-11011/151/2005-
IA.II(I) Dt Aug 11,2005 to manufacture Paracetamol with a capacity of 200
TPM. Subsequently obtained CFE of the Board vide letter No:
62/PCB/CFE/RO-I-RRD/HO/2010-2289 for change of product mix by
adding two low volume products with a total capacity of 193.42 TPM. As
product pricing came down drastically over the period, it is necessary to
achieve economic scale of production. In order to achieve this now Sri
Krishna Pharmaceuticals Limited proposed to expand the production
Capacity from 200 MTPM to 2021.68 MTPM
A copy of the environmental clearance obtained from MOEF, Government
of India in 2005 and certified copy of compliance report obtained MOEF,
Government of India, Bangalore Regional office is enclosed at Annexure
I
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit I
2
2.0 Introduction of the Project
The salient features of the project are described in table below
TABLE 1
Salient Features of the Project
Location C-4, IDA Uppal, Rangareddy
District, Telangana
Longitude and latitude 17°23'33.7"N Latitude and
78°55'0.3"East Longitude.
Year of establishment 1975
Product category 5(F) Bulk Drugs & Intermediates
Project category as per EIA
notification
Category B ( Located in notified
industrial Estate
Proposed Activity Capacity expansion from 200 TPM
to 2021.68 TPM
Total investment on the plant Current - Rs. 35.0 Cores & Proposed
– Rs.90 Crores
Total Investment on
Environmental Infrastructure
Rs. 7.0 Crores (Current) Rs. 20
Crore ( Proposed) – Total 27Crores
Total area of the plant 5.2 Acres
Total area of green belt 1.8 Acres
Water requirement Fresh water requirement after
expansion – 600 KLD
Source of water Hyderabad Metro Water & Sewerage
Board and purchased from out side parties
Nearest habitation and distance from the site
Laxminarayana Nagar – Adjacent to the site on the Southern side
Nearest surface water bodies River Musi – 1.3 KM Hussain Sagar Lake - 7.8 KM in the upstream
Nearest reserve forest 7 Reserve Forests within 10 KM radius
Environmentally sensitive areas within 10 km radius
Hussain Sagar lake at 7.8 KM in the upstream of the site
Any national parks, wild life sanctuaries within 10 km radius
None in 10 KM radius (Kasu Brahmananda Reddy Park –
13.5 KM Nehru Zoo Park - 13.4 KM)
Nearest air port and distance Hyderabad 32 KM
Nearest railway station and
distance
Secunderabad- 13 KM
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit I
3
i) About the Group &Promoters
Sri Krishna Pharmaceuticals Limited,established in the year 1975 under
the companies act 1956. manufacturing bulk drugs and intermediates
(APIs) started its operation in Telangana with its first unit in IDA Uppal to
manufacture Paracetamol. Subsequent to this, group has established a
formulation unit at IDA Nacharam in 2004, bulk drugs manufacturing unit
in Raikunta village, Shamshabad (Mandal) RR District, a Bulk Drug
Manufacturing unit at Plot No. B-14, MIDC, Chincholi in Solapur in the
year 2008.
It had taken over the company named M/s ArandyLaboratories Limited,
IDA Bollaram, Medak Dist and amalgamated in to Sri Krishna group as
unit-IV .
Sri Krishna Group is emerged as major supplier of API’s Internationally
through it’s efforts in quality and reliability. It is currently catering to the
needs of the domestic customers and customers in Europe, US,
Germany, Japan and Latin America.
The group is adopting cleaner environment technologies and complying to
the directions issued by APPCB from time to time. The industry made and
continuously making all efforts to treat liquid solid & Air to achieve
standards prescribed. Upgrading the facilities time to time as per the
technologies available.
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit I
4
3.0 Project Description
3.1 Production Capacity
TABLE 2
List of Existing Products
S.No Name of the Product Quantities
in TPM
1. Paracetamol 188
2 Domperidone 4.05
3 Domperidone Maleate 1.372
Total 193.42
Bi- Products
Acetic acid (32%) 220
3.1.1 Proposed expansion:
It is now proposed to expand the production capacity of the existing 3
products. Below Table provides list of products and proposed capacities.
TABLE 3
Proposed Products & Capacity
S.No Product Name
Producti
on Capacity
TPM
Product
Description
Drug/Intermediate/Multipur
pose chemicals
1 Paracetamol (starting from PNCB Stage)
200.0 Bulk Drug
2 Paracetamol (Starting
from PAP stage) 1800.0
Bulk Drug
3 Domperidone
16.2 Bulk Drug
4 Domperidone Maleate 5.488 Bulk Drug
Total 2021.68
Bi Products
Acetic acid (90%) 846.9
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit I
5
3.2 Manufacturing Process
The Manufacturing process for the above chemicals involves chemical
reactions like oxidation, reduction, acetylization, diazotization etc. The
products of reaction are purified, filtered and dried before packing the
final product. Brief process description and process flow charts are given
at Annexure III
3.3 Raw Materials
List of raw material product wise is given at Annexure II
3.4 Water Requirement
The water requirement will be met partly from HMWS & SB (Hyderabad
Metro Water Works and Sewerage Board) and partly from private
suppliers through tankers. The requirement for water in this unit is for
process and domestic purposes. The water balance for daily consumption
is presented below.
TABLE 4.0
Water Balance– Current & Proposed
S. No
Stream
Water requirement
in KLD
Waste Water
discharge in KLD
Proposed
method of treatment &
disposal
Current After Expansion
Current After Expansion
1 Process
16.58
131.6
23.5
100.26
MEE followed by ATFD.
(Condensate
to ETP & RO)
2 Washings,
R& D Lab 11.0 11.00
MEE followed
by ATFD.
(Condensate
to ETP & RO)
3 Scrubber 35.0 35.00 MEE followed
by ATFD.
(Condensate
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit I
6
to ETP & RO)
4 Acetic Acid recovery
plant
51.20
MEE followed
by ATFD.
(Condensate
to ETP & RO)
5
DM/Softner
RO Plant back ashes
& rejects
30.0 30.00 ETP & RO ( RO Reject
to MEE)
6 Boiler 31.0 134
10.5
13.00
ETP & RO
( RO Reject
to MEE)
7 Cooling
towers 81.92
400
70.00
ETP & RO
( RO Reject
to MEE)
8 Domestic 18.0 30 15.0 24.00
ETP & RO
( RO Reject
to MEE)
9 Gardening 10.0 10 ----- -----
Total 157.50 781.60 49.0 334.46
3.6 Wastes generation and control systems
3.6.1 Liquid Effluents
As detailed in table 4.0 waste water generation after expansion would be
334.46 KLD. It is proposed to segregate effluents into high COD and High
TDS stream and Low COD and Low TDS streams
High TDS and High COD stream would be treated in stripper followed by
MEE and ATFD. The resultant sludge would be disposed to TSDF,
Hyderabad. The Low TDS stream would be treated along with MEE/ATFD
condensates in biological ETP followed by RO. The RO rejects would be fed
back to MEE. The Permeate from RO would be used for cooling tower
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit I
7
make up. Thus the treatment system proposed is based on “Zero Liquid
Discharge” (ZLD) Concept
The schematic diagrams of ETP proposed are given in Figure 1.1 and
Figure 1.2 below
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit I
8
Fig 1.1 Schematic treatment scheme of high TDS effluents
Effluent from Process and Aq. Distillate to cement